Professor Stephan Herzig

Stephan Herzig is Research Director at Helmholtz Munich, Scientific Director of the Helmholtz Diabetes Center, and Director of the Institute for Diabetes and Cancer. He holds a full professorship for molecular metabolic control at the medical faculty of the Technical University Munich and is honorary professor at the University of Heidelberg. After obtaining his PhD from the University of Göttingen in 1999, he moved to the U.S. for a postdoctoral training at the Salk Institute for Biological Studies in La Jolla, California. In 2003, he relocated to Germany to establish an independent junior group at the German Cancer Research Center DKFZ, where he was promoted to department head in 2010. In 2012, he became full professor at the University of Heidelberg and eventually accepted an offer from Helmholtz Munich in 2015.

The Herzig lab aims at identifying novel therapeutic targets for treating metabolic dysfunction.

To date, he has published more than 170 peer-reviewed papers including numerous publications in Nature, Nature Medicine, Nature Metabolism, Science, and Cell Metabolism, and holds several patents. Several prestigious awards have been granted to Stephan Herzig, exemplified by an Emmy-Noether Award (German Research Foundation), a Marie-Curie Excellence Award (European Commission), the Werner-Creutzfeldt Award (German Diabetes Association), and in 2023 the Camillo Golgi Award by the European Association for the Study of Diabetes (EASD). Stephan Herzig is serving the scientific community by several coordinating functions in national and international consortia, and he is Editor-in-Chief of Molecular Metabolism.